BOB (psychedelic)
| Names | |
|---|---|
| Preferred IUPAC name
2-(4-Bromo-2,5-dimethoxyphenyl)-2-methoxyethan-1-amine | |
| Other names
4-Bromo-2,5,β-trimethoxyphenethylamine 2-(4-Bromo-2,5,β-trimethoxyphenyl)ethanamine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C11H16BrNO3 | |
| Molar mass | 290.157 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
BOB, also known as 4-bromo-2,5,β-trimethoxyphenethylamine, is a lesser-known psychedelic drug of the phenethylamine and BOx families. It is the β-methoxy analogue of 2C-B. BOB was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 10 to 20 mg, and the duration listed as 10 to 20 hours. BOB produces an altered state of consciousness, tinnitus, a pleasant tingling throughout the body, and a sense of awareness. Very little data exists about the pharmacological properties, metabolism, and toxicity of BOB.